• education
Search

Ulsicral

Ulsicral

sucralfate

Manufacturer:

Ikapharmindo
Concise Prescribing Info
Contents
Sucralfate
Indications/Uses
Short-term (up to 8 wk) treatment of duodenal ulcer.
Click to view Ulsicral detailed prescribing information
Dosage/Direction for Use
Adult Susp 10 mL 4 times daily. Treatment should be continued for 4-8 wk unless there is demonstrated healing.
Click to view Ulsicral detailed prescribing information
Administration
Should be taken on an empty stomach: Take 1 hr before meals & at bedtime.
Special Precautions
Chronic renal failure & dialysis patients. Pregnancy & lactation. Childn.
Click to view Ulsicral detailed prescribing information
Adverse Reactions
Constipation, dry mouth. Diarrhea, nausea, vomiting, gastric discomfort, flatulence, pruritus, rash, sleepiness, dizziness, back pain, headache.
Click to view Ulsicral detailed prescribing information
Drug Interactions
Reduce bioavailability of cimetidine, fluoroquinolone antibiotics, digoxin, ketoconazole, phenytoin, ranitidine, tetracycline, quinidine, L-thyroxine & theophylline.
Click to view Ulsicral detailed prescribing information
Storage
View Ulsicral storage conditions for details to ensure optimal shelf-life.
Description
View Ulsicral description for details of the chemical structure and excipients (inactive components).
Action
View Ulsicral mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Antacids, Antireflux Agents & Antiulcerants
ATC Classification
A02BX02 - sucralfate ; Belongs to the class of other drugs used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
Presentation/Packing
Form
Ulsicral oral susp 500 mg/5 mL
Packing/Price
100 mL x 1's (Rp42,000/botol);200 mL x 1's (Rp67,000/botol)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in